Led by Tania T. Von Visger, PhD, and Yu-Ping Chang, PhD, the study surveyed 339 adults with COPD. Participants who practice ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

Despite the prevalence of cardiovascular disease, many people are unclear about the role their genes play and how to lower their risk.

Researchers from the Mitochondrial Medicine Program at Children's Hospital of Philadelphia (CHOP) have better characterized a spectrum of what were classically considered discrete mitochondrial DNA ...

EXCLUSIVE: The parents of two siblings with a life-limiting condition are waiting in agony to find out if health chiefs will ...

Central Massachusetts community leaders, business owners, and patients are sounding alarm bells over the calamitous effects ...

Federal scientists warn that Americans could feel the effects of the new administration's devastating cuts for decades to ...

The study found no evidence that geographically limited disasters significantly reduced annual quality performance scores, highlighting the resilience of these programs.

In a world where one in three Americans will succumb to heart disease, Kenneth Blessing's remarkable journey serves as an ...

However, a newer lupus drug, anifrolumab (brand name Saphnelo), has shown promising results in reducing organ damage, ...

Prenatal sleep and pathways to offspring cardiometabolic riskElysia Davis, College of Arts, Humanities & Social ...

In a real-world analysis of patients with advanced RCC, the combination of first-line Bavencio and Inlyta was effective and ...